STAT3 and diabetic kidney disease: Luteolin inhibited the anti‐inflammatory response and OS by suppressing the activity of the signal transducer and activator of transcription 3 (STAT3) pathway, thereby reducing renal fibrosis and delaying the progression of DKD (Hu et al. 2021).